Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?

被引：1
|
作者：
Stephen M Krane
机构：
[1] Professor of Medicine at Harvard Medical School and Massachusetts General Hospital,
来源：
Nature Clinical Practice Rheumatology | 2006年 / 2卷 / 4期
关键词：
D O I：
10.1038/ncprheum0158
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：186 / 187
页数：1
相关论文
共 50 条
  • [1] Is a single infusion of zoledronic acid superior to risedronate for the treatment of Paget's disease?
    Papapoulos, SE
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (05): : 252 - 253
  • [2] Is a single infusion of zoledronic acid superior to risedronate for the treatment of Paget's disease?
    Socrates E Papapoulos
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 : 252 - 253
  • [3] Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease
    Reid, IR
    Miller, P
    Lyles, K
    Fraser, W
    Brown, JP
    Saidi, Y
    Mesenbrink, P
    Su, GQ
    Pak, J
    Zelenakas, K
    Luchi, M
    Richardson, P
    Hosking, D
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (09): : 898 - 908
  • [4] COMPARISON OF A SINGLE INFUSION OF ZOLEDRONIC ACID WITH RISEDRONATE FOR PAGET'S DISEASE
    Mazhar, Raoul
    JOURNAL FUR MINERALSTOFFWECHSEL, 2005, 12 (04): : 143 - 143
  • [5] A single infusion of zoledronic acid is safe and effective for the treatment of Paget's disease
    Marie Lofthouse
    Nature Clinical Practice Endocrinology & Metabolism, 2005, 1 (2): : 66 - 66
  • [6] A single infusion of zoledronic acid 5 mg achieves more sustained biochemical remission versus daily 30 mg risedronate in patients with Paget's disease
    Hosking, D.
    Reid, I.
    Miller, P.
    Brown, J.
    Lyles, K.
    Devogelaer, J. P.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : 423 - 423
  • [7] Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's disease
    Singer, FR
    Clemens, TL
    Eusebio, RA
    Bekker, PJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (06): : 1906 - 1910
  • [8] Determinants of response in patients with Paget's disease treated with zoledronic acid versus risedronate
    Hosking, DJ
    Miller, P
    Brown, J
    Fraser, W
    Lyles, K
    Reid, I
    Mesenbrink, P
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S670 - S671
  • [9] Zoledronic acid produces higher and more rapid therapeutic response rates versus risedronate in patients with Paget's disease
    Miller, P
    Brown, J
    Hosking, D
    Fraser, W
    Lyles, K
    Hunt, P
    Levitt, NS
    Tsoukas, G
    Richardson, P
    Luchi, M
    Saidi, Y
    Su, G
    Zelenakas, K
    Reid, I
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 (06) : 509 - 509
  • [10] Zoledronic acid produces greater and faster efficacy versus risedronate in patients with Paget's disease
    Fraser, W
    Hosking, D
    Miller, P
    Brown, J
    Lyles, K
    Moniz, C
    Diaz-Curiel, M
    Hunt, P
    Levitt, NS
    Pak, J
    Su, G
    Luchi, M
    Zelenakas, K
    Saidi, Y
    Reid, I
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S35 - S35
12345